Broadcom (NASDAQ: BRCM): Current price $33.67
Broadcom has launched a quad-core HSPA+ processor with GPS, 5-gigabyte Wi-Fi, near-field communication, and indoor positioning, according to The Motley Fool. The firm said that the BCM23550 processor was created for high performance entry-level phones, and is constructed for the Android 4.2 Jelly Bean mobile operating system. Beyond that, since the chip works with present-day smartphone designs with similar-sized Broadcom chips, the company termed its new processor a “turnkey solution” which will permit smartphone makers to accelerate their output of full-feature 3-gigabyte smartphones.
Myriad Genetics (NASDAQ:MYGN): Current price $26.84
Since the United States Supreme Court ended patent monopoly over DNA earlier this week, firms and a university are hurrying to provide cheaper and broader genetic testing for breast cancer risk to an increasing group of women. Myriad has had the BRCA1 and BRCA2 genes under patent for over ten years, but hours after the decision, the University of Washington and the closely held Ambry Genetics in California announced that they would immediately offer expanded testing that included the genes, and Quest Diagnostics (NYSE:DGX) said that it would start testing for the genes later in 2013. Geneticists say that when the Court invalidated key portions of Myriad’s patents, it removed a restriction that disallowed labs from employing new tech to develop and sell broader one-time tests that search out all known cancer risks, including the BRCA genes.
Smith & Wesson Holding Corporation (NASDAQ:SWHC): Current price $9.79
The corporation said that it estimates its fourth-quarter results to top prior expectations, pushing shares up by 6.1 percent in early morning trading on Friday. Smith & Wesson has prospered from a surge in demand for guns of late, and now anticipates a 38-percent rise in sales to $179 million for the most recent period. Additionally, it is anticipated that per-share earnings will be near 44 cents, up from 27 cents year-over-year from 2012. The company also reported that its board okayed a debt exchange and a buyback of as much as $100 million in stock, replacing a previous repurchase program.
Don’t Miss: 3 Ways Baby Boomers Are Redefining Retirement.